Lowering cholesterol with inclisiran in people on many medications
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 84 years old and able to give your own consent.
- You are taking 5 or more prescription medications.
- You have high risk of heart disease or stroke, diabetes, or early signs of plaque in your arteries.
- You are on a statin you can tolerate (or cannot take statins) and still have high LDL cholesterol.
- You have not used the study drug inclisiran before and are not allergic to it.
- You do not have active liver disease, uncontrolled diabetes, recent serious heart problems, or other major health issues that would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new version of inclisiran, a cholesterol-lowering medicine, to see if it is safe and works well. The study compares it to the current version. You may qualify if you have moderately high cholesterol but have never taken cholesterol medications.
This study tests if starting inclisiran soon after a heart attack helps lower cholesterol further in patients already on statins. The goal is to see if early treatment can reduce future heart risks.
This study looks at how well people stick with and respond to the cholesterol-lowering drug Inclisiran. It aims to understand if the medicine works well over time in Italian patients.
This study tests a new medicine called inclisiran (a small interfering RNA) to see if it can shrink or stabilize fatty plaques in neck arteries. You may qualify if you have carotid plaques and high LDL cholesterol despite statin use or if you haven't taken statins.
This study tests whether a twice-yearly injection called inclisiran can prevent heart attacks, strokes, or leg complications in people who recently had a procedure to open a blocked artery. You may be eligible if you had a heart or leg artery procedure within the last two weeks.
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
Hear when a new Primary Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.